FDAnews Announces — FDA’s Big 5 Challenges: Agency Tackles Botox, Cannabis, Opioids, Tobacco Intended Use, Right-to-Try Webinar, July 13, 2017

Share Article

The FDA takes up 5 hot-button issues: Botox, cannabis, opioids, right-to-try, and tobacco. Where will President Trump’s newly minted FDA Commissioner, Scott Gottlieb MD, come down on these controversies?

FDAnews

FDAnews

FDA’s Big 5 Challenges:
Agency Tackles Botox, Cannabis, Opioids, Tobacco Intended Use, Right-to-Try
**An FDAnews Webinar**
July 13, 2017 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/big5challenges    

Botox. Cannabis. Opioids. Tobacco intended use. Right-to-try. It’s a regulatory agenda with potentially national, and even global impact.

Drugmakers, food and tobacco processors all stand at risk.

And Donald Trump only multiplies the uncertainties.

Where will President Trump’s newly minted FDA Commissioner, Scott Gottlieb MD, come down on these controversies? What is his staff discussing right now?

FDAnews has enlisted a food and drug law expert with more than 30 years’ experience to bring manufacturers up to speed.

Roseann B. Termini Esq. takes webinar attendees behind the FDA’s closed doors. She’ll dig deep into:

  •     Botox approvals: Black box warnings, patents, scams, Botox® parties, legal implications, state actions
  •     Marijuana regulation: Likelihood of regulation as a drug, “medical marijuana” and the FDA, synthetic marijuana regulation, state and local actions
  •     Opioid Task Force: How its actions could affect Rx drugmakers, potential new regulatory initiatives
  •     The Intended Use Rule: How it might change during the Gottlieb tenure
  •     Right-to-Try Movement: Gaining momentum or losing steam? And what will be the impact on pharmaceutical regulatory and quality operations?

This session is the first ever to tackle all 5 hot-button issues before the FDA.

Meet the Presenter:
Food and drug law expert Roseann B. Termini Esq. is an author, educator and advocate specializing in direct-to-consumer advertising and corporate accountability. As a lawyer she successfully litigated and prosecuted numerous cases involving food and drug law. As an educator she created online food and drug law courses at Widener University Law School. She is editor of the series Life Sciences Law: Federal Regulation of Drugs, Biologics, Medical Devices, Foods and Dietary Supplements and a founding board member of the Center for Pharmaceutical Health Services Research.

Who Will Benefit:

  •     Sales/Marketing
  •     Strategic Planning
  •     Product Developers
  •     Regulatory Affairs/Compliance
  •     QA/QC
  •     Risk Managers
  •     Product Assurance
  •     Enforcement Staff
  •     Scientists

Webinar Details:
FDA’s Big 5 Challenges:
Agency Tackles Botox, Cannabis, Opioids, Tobacco Intended Use, Right-to-Try
**An FDAnews Webinar**
July 13, 2017 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/big5challenges    

Tuition:
$287 per site

Easy Ways to Register:
Online: http://www.fdanews.com/big5challenges                                                                                        
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website